4.94
-0.05 (-1.00%)
| Penutupan Terdahulu | 4.99 |
| Buka | 4.95 |
| Jumlah Dagangan | 420,582 |
| Purata Dagangan (3B) | 581,350 |
| Modal Pasaran | 229,541,632 |
| Harga / Jualan (P/S) | 2.40 |
| Harga / Buku (P/B) | 1.13 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Nov 2025 |
| Margin Keuntungan | -35.28% |
| Margin Operasi (TTM) | -86.92% |
| EPS Cair (TTM) | -1.24 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -5.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 11.51% |
| Nisbah Semasa (MRQ) | 8.29 |
| Aliran Tunai Operasi (OCF TTM) | -28.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -6.46 M |
| Pulangan Atas Aset (ROA TTM) | -9.38% |
| Pulangan Atas Ekuiti (ROE TTM) | -14.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Quanterix Corporation | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.20 |
|
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.66% |
| % Dimiliki oleh Institusi | 89.70% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Easterly Investment Partners Llc | 30 Jun 2025 | 1,083,635 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| TOLOUE MASOUD | - | 7.26 | -254 | -1,844 |
| Jumlah Keseluruhan Kuantiti Bersih | -254 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,844 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 7.26 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| TOLOUE MASOUD | Pegawai | 30 Nov 2025 | Dibuang (-) | 254 | 7.26 | 1,844 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 20 Nov 2025 | Pengumuman | Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth |
| 17 Nov 2025 | Pengumuman | Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring |
| 10 Nov 2025 | Pengumuman | Quanterix Releases Financial Results for the Third Quarter of 2025 |
| 03 Nov 2025 | Pengumuman | Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |